Publications

The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) is a prospective, randomized, placebo-controlled trial of a statin strategy for the primary prevention of major adverse cardiovascular events in people living with HIV with low to moderate traditional risk

Studying how NK cell education status infleunces Ab-dependent cellular cytotoxicity levels

Studying the relationship between plasma levels of CXCL13 and systemic immune activation during the early phases of infection and during ART

Assessing the effectiveness of human papillomavirus (HPV) vaccination in women with and without human immunodeficiency virus (HIV)

Studying HIV transmissions dynamics among men who have sex with men

Assessing how patient characteristics and hepatitis C coinfection affect treatment amongst people living with HIV

Studying the retention of antiretroviral therapy in Zomba district, Malawi, after the introduction of Universal Test and Treatment

Studying the birth rates of women living with HIV compared to the general population in BC

Estimating the impact of HIV-related stigma on brain health and everyday functioning among 512 older white men living with HIV in Canada

Marion Di Ciaccio, Luis Sagaon-Teyssier, Christel Protière, Mohamed Mimi, Marie Suzan-Monti, Laurence Meyer, Daniela Rojas CastroGilles PialouxClaire PintadoJean Michel MolinaMarie PréauBruno Spire